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Abstract  
Objective: For many patients with chronic conditions, such as COPD, the assistance of 
family carers with medicines is vital for optimal treatment outcomes. The aim of this study 
was to identify the assistance carers provide to COPD patients using nebuliser-delivered 
therapy at home, and the problems experienced which may impact on the safety and 
effectiveness of therapy and contribute to carer-burden.  
Methods: A cross-sectional, qualitative descriptive study was conducted with participants 
recruited from primary and intermediate care. Home interviews were conducted with 14 
carers who assisted a family member with COPD using a nebuliser. Qualitative procedures 
enabled analysis of nebuliser-related activities and problems experienced by carers.  
Results: The carer sample included 10 female and 4 male carers, with a mean age of 61 
years: 11 spouses and 3 daughters. They had assisted patients with use of their nebuliser 
and associated medications for, on average, 4.5 years. Assistance ranged from taking full 
responsibility for nebuliser use to providing help with particular aspects only when required. 
Nebuliser-related activities included assembling and setting up equipment, mixing 
medicines, operating the device, dismantling and cleaning equipment. Difficulties were 
described with all aspects of care. Carers reported concerns about medication side-effects 
and the lack of information provided.  
Conclusion: The study revealed the vital role of carers in enabling effective therapy. The 
wide-ranging responsibilities assumed by carers and problems experienced relate to all 
aspects of COPD management with nebulisers, and have a potential impact on treatment 
outcomes and carer-burden. A systematic approach to addressing carers’ needs and 
prioritising support would be anticipated to have positive consequences for patients, carers 
and health services.  
Keywords: COPD, nebulisers, family carers, medicines optimisation, pharmaceutical care 
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What is known about this topic:  
 Effective management of COPD for many patients in their homes depends on the 
correct use of their nebuliser.  
 Many patients with chronic illness depend on a family carer for assistance with 
medicines. 
 Assistance provided by family carers is often vital for successful outcomes, but can 
lead to significant carer-burden. 
What this paper adds:  
 Family carers who provide vital assistance in the home for patients with COPD 
depending on a nebuliser can experience problems with all aspects of its 
management and use.  
 Responsibilities and problems experienced by carers in nebuliser-related activities 
will potentially impact on both treatment outcomes and carer-burden.  
 A systematic approach to supporting family carers would have positive 
consequences for patients, carers and health services. 
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Introduction 1 
 2 
Patients with COPD may be prescribed domiciliary nebuliser therapy as part of a disease 3 
management plan.[1, 2] Nebulisers are used to deliver drugs with large therapeutics doses, 4 
e.g. antibiotics, or for patients, such as the elderly and infirm, who have difficulties with 5 
handheld inhalers, where inhaling drug from a nebuliser using normal tidal breathing is 6 
advantageous. Effective use of medicines (especially inhalation therapy) is essential for 7 
successful disease management of COPD patients. Exacerbations of disease and/or 8 
treatment failures may result in hospitalisation and constitute a significant burden to both 9 
patients and health services. 10 
 11 
Nebulisers are complex to use, requiring assembly of equipment, dosing, frequently mixing 12 
with diluents, inhalation over several minutes, then dismantling, washing, sanitising and 13 
drying the equipment.[3] Patients with COPD have physical and functional limitations and 14 
often depend on help from family members who provide vital care.[4-9] Reasons for reliance 15 
on carers include breathlessness, co-existing disabilities, visual impairment and arthritis.[4]  16 
 17 
Medicines-related activities are an integral part of caring, and many patients with long-term 18 
illness depend on a family carer for assistance with medicines use.[10-13] Carers’ roles can 19 
include monitoring and maintaining medication supplies, assisting with drug administration, 20 
reminding and advising on doses and frequency, monitoring and advising on side-effects, 21 
and sourcing information.[11, 12] Their level of involvement ranges from assisting with a 22 
small (but often significant) number of activities to taking full responsibility for all aspects of 23 
medication.[12] Although a few studies have examined the impact on family carers of caring 24 
for someone with COPD, these have not examined medicines-related aspects.[6, 9, 14-16]. 25 
However, there is some evidence from the USA that assistance from a carer may be 26 
associated with improved medication adherence in COPD patients.[17] A recent review 27 
highlighted the paucity of information on the needs of family carers for people with COPD.[8] 28 
 29 
The important contribution of family carers to health care is widely accepted and support for 30 
carers has been identified as a policy priority.[18-20] The Royal College of General 31 
Practitioners emphasises the importance of drawing on carers’ experiences in informing 32 
service development.[21]  33 
 34 
For these patients achieving optimal therapeutic outcomes to prevent hospitalisation, will 35 
depend on effective nebuliser use. Currently, little is known about the assistance family 36 
carers provide to COPD patients using nebuliser therapy, and the specific problems they 37 
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experience. The aim of this study is to identify the roles and perspectives of carers assisting 38 
such patients, and to inform strategies that will enable healthcare professionals to support 39 
carers in their roles, reduce carer-burden and optimise health outcomes. 40 
 41 
Methods  42 
 43 
This was a descriptive study employing qualitative methods. Data were collected in semi-44 
structured interviews in carers’ homes. Participants were identified from two settings: one 45 
primary care setting comprising 38 GP surgeries and one intermediate care setting 46 
(healthcare and rehabilitation team located at a major acute hospital). Together, these 47 
settings enabled involvement of carers of patients whose disease management may be 48 
stable in the community, and carers who assisted patients recently admitted to hospital with 49 
an exacerbation, possibly indicating treatment failure. All patients eligible to participate in the 50 
study were identified by collaborators at the study sites. Patients with a confirmed COPD 51 
diagnosis, prescribed nebules/Respules® and/or Combivent® (ipratropium and salbutamol) 52 
for use with a nebuliser in their home were identified. Patients with mental health problems, 53 
severe cognitive impairment, were unwell or had a serious illness (e.g. advanced cancer) 54 
were excluded from the study. An invitation pack was forwarded to all patients who were 55 
asked to identify any relative or a friend from whom they received assistance with their 56 
nebuliser. This pack also included an information leaflet and reply slip for carers. Home 57 
interviews were arranged with carers who returned a reply slip indicating their willingness to 58 
participate. An analysis of patients’ practices and experiences of nebulisers was also 59 
undertaken and has been reported separately (Alhaddad B et al, 2015). 60 
 61 
The semi-structured interview schedule comprised structured and open questions. 62 
Structured questions were used to identify the range and extent of assistance provided by 63 
carers with nebuliser use. Open questions enabled detailed discussion of carers’ 64 
experiences and difficulties regarding all aspects of their assistance and actions taken to 65 
resolve problems. The interview schedule gathered details about the assistance provided 66 
with respect to decisions regarding the need for therapy, setting up and operating the 67 
nebuliser, cleaning, maintenance and maintaining supplies, liaison with health care providers 68 
and suppliers, and information sources. The researcher was PhD student with a pharmacy 69 
background and training in qualitative methods. Her expertise in therapeutic and technical 70 
aspects of nebuliser use, enabled the identification and examination of all aspects from the 71 
perspectives of the carers. Informed consent was obtained with the researcher prior to the 72 
commencement of each interview.. All interviews were recorded and data transcribed 73 
verbatim. The Framework approach was employed in the analysis.[22] This matrix-based 74 
6 
 
analytical method enables a systematic approach to data analysis, whilst allowing 75 
application of qualitative procedures.  Initial themes were guided by the domains of the 76 
interview schedule to include all aspects of nebuliser use. Qualitative procedures (constant 77 
comparison) were applied within this framework to ensure that findings were a true reflection 78 
of carers’ practices, experiences and perspectives in all domains.   79 
Data analysis was facilitated by use of the FRAMEWORK software developed by NatCen 80 
specifically to support the framework method. Ethics approval was obtained prior to 81 
commencement of the study. 82 
 83 
Results  84 
 85 
Response rate and characteristics of the carers  86 
180 patients were sent invitation packs; 83 returned the reply slip and 60 agreed to 87 
participate. 15 respondents reported that they were assisted by a family carer, 14 of whom 88 
agreed to take part and were interviewed. The carer sample included 10 female and 4 male 89 
carers, with a mean age of 61 years (range 26–79). Eleven were spouses and 3 daughters; 90 
all living with the patient. On average, the carers reported that they had assisted with 91 
nebuliser therapy for about 4.5 years and spent approximately 3.5 hours per week (range 1 92 
to 10.5 hours) on nebuliser-related activities. They provided assistance with a mean of 6 93 
different nebuliser-related activities (range 2 to 9) and reported encountering an average of 3 94 
difficulties (range 0-9) whilst providing this assistance (Table 1).   95 
 96 
Table 1 97 
 98 
The results are described under three main themes:  assistance in decisions regarding the 99 
need for therapy including advice on doses and the need for emergency help; setting up and 100 
operating the nebuliser including cleaning, maintenance and obtaining supplies; and 101 
obtaining information.   102 
 103 
Assistance in decisions regarding the need for therapy Decisions regarding nebuliser 104 
therapy included the need to initiate the therapy (n=6), adjusting doses (n=1), withholding a 105 
dose (n=1), or giving advice on discontinuation of therapy (n=1). Advice to use therapy was 106 
in response to noticing or hearing their relative experiencing breathing difficulties, or as a 107 
precautionary measure prior to an anticipated increase in the patient’s physical activity, 108 
which might trigger breathlessness. Carers expressed concerns with regard to knowing 109 
when to initiate therapy and the frequency of dosage:  110 
 111 
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We didn’t want to have it (nebuliser therapy) because… he puts on a lot of weight, he 112 
fills with water, but he said – don’t worry, it’s better to start it straight away than to 113 
wait.  We used to wait until he couldn’t breathe at all, you see?   114 
Female, 74 yrs old, assisting for 4 yrs 115 
 116 
 117 
Concerns were raised by carers about safety, the patient developing tolerance and side-118 
effects of nebulised medication. Differing perspectives of carers and patients about the need 119 
for medication were sometimes revealed.  120 
 121 
Some days he looks like he’s got the shakes for that is the Ventolin® anyway, 122 
because that does make you shake because I’ve been on that myself in the past and 123 
yeah... that wears off doesn’t it after a while, but he does, I just leave him to sit quiet, 124 
I watch him, he doesn’t always know that I’m watching him. 125 
Female, 66 yrs old, assisting for 5 yrs 126 
 127 
Well, when she’s bad she’ll use it [the nebuliser] up to four times a day; when she’s 128 
good maybe only once or twice.  So she tries not to use it, she’s stubborn; she tries 129 
her hardest not to use it. 130 
Female, 26 yrs old, assisting for 5 yrs 131 
 132 
Carers reported contacting a doctor or calling for an ambulance when nebulised therapy 133 
failed to relieve the patient’s breathlessness. However, difficulties in recognising the 134 
symptoms of an exacerbation and distinguishing them from other symptoms related to age 135 
or underlying conditions were experienced. Unclear information received from healthcare 136 
professionals further complicated this task: 137 
 138 
... the receptionist said to me “do her lips go blue?” Well her lips don’t always go 139 
blue. At one point they ask me is her lips blue..., and I said “no” and then we got an 140 
emergency doctor in; he took her oxygen levels and said “oh my god she’s got to go 141 
to a hospital immediately, they’re so low”, and I said “blue lips is not an indication 142 
necessarily because she lives on low oxygen levels anyway”... 143 
Female, 60 yrs old, assisting for 10 yrs 144 
 145 
Setting up and operating the nebuliser  146 
The compressor, used to generate an aerosol from fluid placed in the nebuliser chamber can 147 
be noisy in operation. To overcome this, one carer described how her mother covered the 148 
nebuliser with a duvet to silence it during night-time use. The weight of the compressor could 149 
be problematic, e.g. necessitating the use of a trolley on excursions. Being unable to use the 150 
nebuliser in the event of a power cut, as the nebuliser required mains electricity was also of 151 
concern.  152 
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Carers described assisting with connecting tubing between the nebuliser chamber and 153 
compressor, pouring drug fluid into the medication reservoir, screwing the cap back on the 154 
chamber, and connecting the facemask or mouthpiece to the device before giving the 155 
nebuliser to the patient to start inhaling the nebulised dose:  156 
 157 
He can’t put the solutions in when things are bad. He doesn’t understand which ones 158 
to put in. He couldn’t tell the difference between the two; the antibiotic and the other 159 
one.  So he does need somebody to make sure he is doing it properly. 160 
Female, 64 yrs old, assisting for 3 yrs 161 
 162 
Some carers reported technical difficulties; especially related to over-stretched tubing, but 163 
also to the lengthy process of setting up and operating nebulisers when medication was 164 
needed immediately and uncertainty regarding dilution of the medication (usually with 165 
physiological saline): 166 
 167 
Sometimes this [tubing] does come off. It sort of blows off you know and we have to 168 
keep pushing it back on and that doesn’t stay in there too well.  169 
Female, 67 yrs old, assisting for 4 yrs 170 
 171 
...that’s the bit that we’re not sure about because sometimes he uses distilled water, 172 
sometimes he doesn’t put any water in and I don’t know if that’s right. 173 
Female, 29 yrs old, assisting for 10 yrs 174 
 175 
During nebulisation, carers may assist in fitting the mask to the patient’s face and advising 176 
on their breathing pattern, sometimes being concerned whether full effectiveness was 177 
achieved:  178 
I have to say I don't think he does enough deep breathing....I say come on breathe in 179 
and breathe out.  180 
Female, 75 yrs old, assisting for 0.5 yrs 181 
 182 
Dismantling and cleaning 183 
Dismantling the nebuliser system after use and subsequent cleaning is essential. Carers 184 
described washing nebuliser parts with warm soapy water, wiping the compressor and 185 
disinfecting parts with commercial detergent. Some reported that these tasks may not be 186 
undertaken when they were unavailable. Difficulties in dismantling the device were reported, 187 
resulting from poor manual dexterity due to arthritis, poor maintenance or understanding of 188 
the nebuliser parts. In two cases, carers described incidents where the tubing was stuck and 189 
could not be detached from the nebuliser. Two others expressed concerns over blocked 190 
tubing which could not be cleaned properly.  191 
 192 
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Maintenance, servicing and obtaining parts 193 
Carers invariably took responsibility for purchasing or obtaining disposable components 194 
(nebuliser, facemask, mouthpiece, tubing); booking, and taking the nebuliser for servicing or 195 
repair. They reported difficulties in accessing disposable parts through the hospital or local 196 
surgery, and revealed health professionals were uncertain about whether (or under what 197 
circumstances) different items could be provided. Other concerns included: non-availability 198 
of nebuliser services, lengthy procedures for obtaining a nebuliser, lack of information on 199 
maintenance and fears of being without a nebuliser if equipment failed. When relying on 200 
private suppliers, the costs, practicalities of trips to manufacturers and their agents, and 201 
problems obtaining required items and quantities were raised:  202 
 203 
We bought packages from the company and you get loads of stuff you don’t need. 204 
You know you couldn’t buy the tubes without [the nebuliser], you know on their own, 205 
and that kind of thing; you’re like paying £20 for a package with loads of stuff you 206 
don’t use. 207 
Female, 60 yrs old, assisting for 10 yrs 208 
 209 
Carers were commonly responsible for ordering and collecting supplies of nebuliser 210 
medication from doctors’ surgeries and pharmacies.  211 
 212 
Obtaining information 213 
Carers drew on a variety of information sources: GPs, manufacturers’ instruction manuals, 214 
medication leaflets and family members with medical backgrounds. A range of information 215 
needs were outlined: frequency of dosage, required volume of nebuliser fluid, adverse 216 
effects, nebuliser cleaning and maintenance, and actions to be taken in case of treatment 217 
failure or equipment breakdown. The use of several inhaler devices (nebuliser users 218 
frequently also use handheld inhalers) was a source of confusion for some carers. 219 
Inconsistent information and lack of understanding of changes to prescriptions or regimens 220 
also caused problems:   221 
My husband is on three different inhalers, so we weren’t entirely sure how they really 222 
work... He was told to take them, but we weren’t really sure what we were supposed 223 
to be doing. 224 
Female, 67 yrs old, assisting for 4 yrs  225 
 226 
The responsibility for managing medication, with limited knowledge and understanding could 227 
be stressful:   228 
 229 
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I’m not a doctor and I’m not a nurse and they mustn’t view me as that... they can do 230 
this, but at the end of the day [...] if something bad happened to her, I would say “is 231 
that me?’ ‘Did I do that?” 232 
Female, 60 yrs old, assisting for 10 yrs 233 
 234 
 235 
Discussion  236 
-Figure 1- 237 
 238 
Figure 1 illustrates the study findings, indicating the potential impact on patients’ medicines-239 
related outcomes and carer-burden.  240 
 241 
The responsibilities assumed by carers and the problems and concerns experienced varied 242 
hugely, and apply to all aspects of nebuliser use.  243 
 244 
Previous research has acknowledged that older people with COPD depend on a carer for 245 
assistance, potentially resulting in considerable carer-burden.[8, 9, 14-16, 23, 24] However, 246 
in these studies there has been little focus on assistance with medicines, which is vital for 247 
treatment outcomes, yet contributes to carer-burden.[25] One such study did identify, from 248 
patients’ and carers’ perspectives, that nebulisers conferred benefits that outweighed their 249 
disadvantages especially when compared to other inhalation devices, but did not discuss 250 
nebuliser-related support and problems.[26] The present study details the extent of support 251 
and range of activities with nebulisers for which carers assumed responsibility. This included 252 
practical assistance specific to nebuliser use and maintenance, organizational and 253 
therapeutic roles, such as obtaining and administering medication, making clinical judgments 254 
on the need for medication and in response to side-effects, and seeking information from a 255 
range of sources.  256 
 257 
Respondents indicated several concerns which should be addressed to permit them to 258 
ensure optimal nebuliser use. Currently, whilst nebuliser medication is prescribable in the UK 259 
on the NHS, equipment, including compressors, nebulisers, facemasks, mouthpieces and 260 
connecting tubing are not. Hence, the sources and use of equipment are not standardised, 261 
with patients receiving equipment from GP surgeries, local hospitals, charities or purchasing 262 
it themselves. This presents problems for patients and their carers who are themselves 263 
frequently elderly. The carers commented on difficulties with obtaining equipment, the 264 
associated costs, problems of getting equipment (constantly used) serviced, and the cost of 265 
“disposable” items which came packaged with unneeded sundries. 266 
 267 
11 
 
Some concern was expressed regarding poor portability of nebuliser equipment and the 268 
constant need for a power supply. Portable nebulisers with rechargeable battery packs are 269 
commercially available. Such devices should be made available, where appropriate, to this 270 
patient group. 271 
 272 
Nebuliser equipment including the nebuliser chamber, tubing and mouthpiece requires 273 
regular washing and disinfection, according to manufacturers’ recommendations. Even in 274 
this small sample problems associated with cleaning were evident, either due to the 275 
practicalities of dismantling and cleaning the equipment or, as this activity was frequently 276 
undertaken by carers, it was not done in their absence. Nebuliser medications are 277 
unpreserved and inadequate cleaning and decontamination may lead to microbial 278 
colonisation of equipment, posing an infection risk to the patient,[27, 28] potentially leading 279 
to hospitalisation. 280 
 281 
In addition to nebuliser-specific activities and problems, the carers expressed concerns 282 
about overdosing, difficulties in determining the correct dose, care-recipient’s reluctance to 283 
use medication, perceived need for more information from healthcare professionals, worries 284 
about disruption in medication supply, the complexities of obtaining disposable parts and 285 
nebuliser maintenance, and the level of vigilance required to monitor the care-recipient’s 286 
condition. All have potential implications for optimal medicines use, adherence to dosing 287 
regimens and therapeutic outcomes.  These concerns also contribute to carer-burden.[25] 288 
 289 
Strengths and limitations of this study 290 
Carers were recruited through primary and intermediate care, permitting involvement of 291 
carers of a diverse patient group. Interviews were conducted in the patient’s homes, 292 
enabling a detailed examination and discussion of nebuliser-related activities.  There are 293 
several limitations: the sample was confined to 15 people who identified themselves as 294 
carers. It is possible others, who perceive they provide only limited assistance (which could 295 
be vital to patient care) did not consider themselves eligible, and were therefore excluded. 296 
Carers from residential homes or other community day care services who have responsibility 297 
for patients, and who may face different challenges were not included. It is also possible that 298 
carers experiencing the highest levels of burden were not well represented in this study, 299 
being reluctant to participate due to time constraints.  300 
 301 
Implications for policy, practice  and future research  302 
The UK Government recognises the important role of family carers and their contribution to 303 
health care, potentially enabling older people to remain in their own homes for longer,[18]  a 304 
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desire shared by patients and important to carers. Support for family carers has been 305 
identified by the UK Department of Health, as a policy priority.[18-20]  A system of support 306 
that specifically includes carers and addresses their needs and difficulties should be a 307 
priority for health professionals. The Royal College of General Practitioners acknowledges 308 
the importance of service developments for carers being informed by their views and 309 
experiences.[21] This paper provides detail on needs and problems from the perspective of 310 
carers to inform future proposals. Sub-optimal domiciliary use of nebulisers by patients with 311 
COPD is a potential source of treatment failure leading to hospitalisation. Thus, health 312 
professionals need to identify patients who rely on carers regarding the use of their 313 
nebulisers. They should ensure that interventions and consultations are arranged to enable 314 
the involvement of carers, so that their roles and needs can be addressed.  Future research 315 
should focus on interventions to improve support for carers (especially when treatment 316 
commences and regimens are changed). Potential interventions should be evaluated firstly, 317 
in terms of their feasibility and acceptability to patients, carers and health professionals and 318 
secondly, in terms of their impact in  reducing carer-burden and optimising disease 319 
management in the community.  320 
 321 
Conclusion 322 
Although the sample was small, the study demonstrated that the optimal use of nebulisers 323 
by patients with COPD is inextricably linked to the roles and responsibilities of family carers. 324 
A systematic approach to addressing the needs of carers is anticipated to have an impact on 325 
patients’ outcomes, health services and carer-burden.  326 
  327 
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Table 1. The number of family carers assisting, and reporting difficulty, 
with each activity (n=14) 
Activity  No. of carers 
performing  
activity  
No. of 
carers 
reporting 
difficulty 
Making decisions on the need to use the nebuliser  8 4 
Supervising the nebulisation process 9 4 
Setting up and operating the nebuliser 12 8 
Assisting with inhaling the nebulised medication 3 1 
Dismantling and cleaning the nebuliser 10 7 
Maintaining supplies of disposables (e.g. tubing) and 
condition of the nebuliser 
9 6 
Maintaining supply of nebulised medication 11 4 
Making decisions to seek help in an emergency 8 3 
Monitoring side effects of nebulised medication 11 3 
Gathering information on the use or safety of nebuliser 8 2 
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Figure1: Family carers who assist COPD patients with nebulisers: potential impact on treatment outcomes and carer-burden   
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